Bitcoin, Ethereum ETFs rake in over $1 billion as institutional demand grows
Bitcoin and Ethereum spot ETFs recorded a combined $1.048 billion in net inflows on Sept. 12, marking one of the strongest single-day institutional demand periods since the products launched.
- Bitcoin ETFs saw $642 million inflows, pushing total net inflows to $56.8 billion overall
- Ethereum ETFs rebounded with $405 million inflows after last week’s sharp outflows
- Analysts say BTC, ETH charts show bullish setups with new highs in sight soon
Bitcoin ( BTC ) ETFs led the charge with $642.35 million in daily inflows and have pushed cumulative net inflows to $56.83 billion. Ethereum ( ETH ) ETFs contributed $405.55 million, bringing their total net inflows to $13.36 billion.
Ethereum ETFs show a strong recovery pattern
Ethereum ETFs have shown a turnaround in investor sentiment during the week ending September 12.
After recording $787.74 million in outflows the previous week, the funds attracted $637.69 million in weekly inflows.
The swing from outflows to significant inflows within one week shows volatile but ultimately positive institutional sentiment toward Ethereum.
The $405.55 million single-day inflow on Sept. 12 is one of the strongest daily performances since the Ethereum ETF launches.
Bitcoin ETF flow data
Weekly data shows the institutional buying momentum building over time. Bitcoin ETFs attracted $2.34 billion in net inflows for the week ending September 12, with total value traded reaching $16.65 billion. This is a strong recovery from the previous week’s more modest $246.42 million in inflows.
Technical levels point to more upside
The ETF inflows align with bullish technical developments across both assets. Analyst Ted noted that Ethereum’s reclaim of $4,700 sets up a test of $4,880 resistance, with new all-time highs possible if that level breaks.
The analyst also mentioned that a failure to breach this key resistance could cause a market correction.
BitBull highlighted Bitcoin’s reclaim of its eight-year trendline and called it a strong technical signal.
The analyst noted Bitcoin lost this level last month, but bulls have now closed a strong candle above it. This suggests the momentum is building for a new all-time high within two to three weeks.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Safe Haven Amid AI Crash! Major Pharmaceutical Stocks Approach Historic Highs
Amid concerns over AI capital expenditures, funds are seeking a "certainty premium." State Street Healthcare ETF reached a record high. Eli Lilly and AbbVie are both approaching their historical highest closing prices, while Gilead and Amgen have surged 7.7% and 7.2% respectively over the past five days. Eli Lilly continues to bet on the future through its GLP-1 dominance and 40 M&A deals totaling $20 billion. AbbVie's core drug Skyrizi has shown positive data for its new subcutaneous formulation, which is expected to extend its patent and drive additional sales.

Fed Officials Turn Hawkish: Daly Says Supply Shocks Should No Longer Be "Wait-and-See," Hammack Suggests More Aggressive Rate Hikes May Be Needed if Inflation Expectations Become Entrenched
San Francisco Fed President Daly stated that the traditional "wait and see" approach to supply-side shocks has been abandoned, noting that businesses in her district are tending to pass rising costs on to consumers and that current inflation risks are "skewed fully to the upside." Cleveland Fed President Hammack said that once the public forms an "inflationary mindset," the difficulty of monetary policy regulation will increase significantly, and the required interest rate hikes will then exceed expectations.

Australian Dollar crumbles as job losses shatter RBA rate hike hopes

Over $10 billion in market value evaporated in four trading days as CoreWeave (CRWV.US) debt risks trigger sell-off, but Deutsche Bank sees it as a buying opportunity
Deutsche Bank believes that the recent sell-off of CoreWeave lacks sufficient company fundamentals to justify it, and the sharp price correction has instead created a buying opportunity for investors.

